Mitochondrial Dysfunction and Oxidative Damage in Alzheimer's and Parkinson's Diseases and Coenzyme Q10as a Potential Treatment
Top Cited Papers
- 1 August 2004
- journal article
- review article
- Published by Springer Nature in Journal of Bioenergetics and Biomembranes
- Vol. 36 (4) , 381-386
- https://doi.org/10.1023/b:jobb.0000041772.74810.92
Abstract
There is substantial evidence that mitochondrial dysfunction and oxidative damage may play a key role in the pathogenesis of neurodegenerative disease. Evidence supporting this in both Alzheimer's and Parkinson's diseases is continuing to accumulate. This review discusses the increasing evidence for a role of both mitochondrial dysfunction and oxidative damage in contributing to β-amyloid deposition in Alzheimer's disease. I also discuss the increasing evidence that Parkinson's disease is associated with abnormalities in the electron transport gene as well as oxidative damage. Lastly, I reviewed the potential efficacy of coenzyme Q as well as a number of other antioxidants in the treatment of both Parkinson's and Alzheimer's diseases.Keywords
This publication has 95 references indexed in Scilit:
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Novel mitochondrial DNA mutations in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Superoxide activates mitochondrial uncoupling proteinsNature, 2002
- Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative StressJournal of Neurochemistry, 1998
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Suppression of Mitochondrial Succinate Dehydrogenase, a Primary Target of β‐Amyloid, and Its Derivative Racemized at Ser ResidueJournal of Neurochemistry, 1995
- Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitroNature, 1995
- Abnormality of the α‐ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's diseaseAnnals of Neurology, 1994
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986